Solak v. Eltragenyx Pharmaceutical Inc.

• Court: Supreme Court of Delaware
• Decided: April 30, 2020
• Docket: 452, 2019
• Status: Published

Opinion

IN THE SUPREME COURT OF THE STATE OF DELAWARE

JOHN SOLAK, derivatively on behalf of § ULTRAGENYX PHARMACEUTICAL § INC., § No. 452, 2019 § Plaintiff-Below, § Appellant, § Court Below: § Court of Chancery v. § of the State of Delaware § DANIEL G. WELCH, EMIL D. § KAKKIS, M.D., PH.D., WILLIAM § No. 2018-0810-KSJM ALISKI, DEBORAH DUNSIRE, M.D., § LARS EKMAN, M.D., PH.D., § MATTHEW K. FUST, MICHAEL § NARACHI AND CLAY B. SIEGALL, § PH.D., § § Defendants-Below, § Appellees, § § and § § ULTRAGENYX PHARMACEUTICAL § INC., A DELAWARE § CORPORATION, § § Nominal Defendant-Below, § Appellee. §

Submitted: April 15, 2020 Decided: April 30, 2020

Before VALIHURA, VAUGHN, and MONTGOMERY-REEVES, Justices.

ORDER

Now this 30th day of April, 2020 having considered this matter on the briefs of the

parties and the record below, and having concluded that the same should be affirmed on the basis of and for the reasons assigned by the Court of Chancery in its Memorandum

Opinion dated October 30, 2019;

NOW, THEREFORE IT IS ORDERED that the judgment of the Court of Chancery

be, and the same hereby is, AFFIRMED.

BY THE COURT:

/s/ Karen L. Valihura Justice